Excited to share our new study on AML-associated HLH, published in Blood Neoplasia.
We evaluated the clinical features, outcomes, and genomic landscape of AML patients who developed HLH across Mayo Clinic sites.
https://t.co/b28wzr1kpN
Honored to be part of this @sitcancer guideline on IO for #KidneyCancer
This work offers evidence- & consensus-based recommendations for adjuvant & metastatic RCC, special populations, response monitoring, & patient education/QOL @DrRanaMcKay@montypal
https://t.co/HkwhHm3Brm
Next destination: South Dakota!
Happy to share that I matched at University of South Dakota for Internal Medicine Residency.
Extremely grateful for everyone who believed in me during this process.
#Match2026@usd
Excited to share that I have matched into Internal Medicine at University of Tennessee – Maury Regional Medical Center, Columbia.
Looking forward to this new journey, learning, growth, and the opportunity to serve patients and the community.
@MauryRegional@UTHSC_Medicine
Presenting our real-world outcomes with belzutifan in pretreated RCC at #ASCOGU26.
Belzutifan demonstrated meaningful landmark PFS rates in a heavily pretreated cohort.
Thanks to our mentors @ZakhariaYousef@IrbazRiaz@Parminder1699